Tango Therapeutics (TNGX) Interest & Investment Income (2020 - 2021)
Tango Therapeutics' (TNGX) quarterly Interest & Investment Income came in at $5634.0 in Q2 2021, down 78.87% quarter-over-quarter from $26666.0 in Q1 2021.
Tango Therapeutics (TNGX) Interest & Investment Income (2020 - 2021) Analysis & Trends
Tango Therapeutics' Interest & Investment Income history runs 2 years deep, the most recent figure standing at $5634.0 for Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Tango Therapeutics | 3.82 Bn | 3.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 5,634.00 |
| Mar 31, 2021 | 26,666.00 |
| Dec 31, 2020 | 65,246.00 |